Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells

被引:48
作者
Zhao, Lixing [1 ]
Wu, Yeke [1 ]
Xu, Zhenrui [1 ]
Wang, Hui
Zhao, Zhihe [1 ]
Li, Yu [1 ]
Yang, Pu [1 ]
Wei, Xing [1 ]
机构
[1] Sichuan Univ, W China Coll Stomatol, Dept Orthodont, State Key Lab Oral Dis, Chengdu 610041, Peoples R China
关键词
hypoxia; endothelial cells; angiogenesis; COX-2; PGE2; signalling; VEGF; AQP1; GROWTH-FACTOR EXPRESSION; INDUCIBLE FACTOR-I; FACTOR-KAPPA-B; PROSTAGLANDIN E-2; UP-REGULATION; CYCLOOXYGENASE-2; EXPRESSION; VASOCONSTRICTOR PROSTANOIDS; VEGF EXPRESSION; GENE-EXPRESSION; PROTEIN-KINASE;
D O I
10.1111/j.1582-4934.2011.01479.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To evaluate the impact of hypoxia on the angiogenic capability of endothelial cells (ECs), and further investigate whether the cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) signalling is involved in the angiogenic response of ECs to hypoxia. We explored the impact of various periods (1, 3, 6, 12, 24 hrs) of hypoxia (2% O2) on human umbilical vein endothelial cells (HUVECs) in vitro. We observed cell viability, migration, tube formation, analysed COX-2, vascular endothelial growth factor (VEGF), AQP1 mRNA transcription, protein expression and measured PGE2, VEGF protein concentration in cell supernatants. Then we treated HUVECs with COX-2 selective inhibitor NS398, EP1/2 combined antagonist AH6809 and exogenous PGE2 to investigate the role of COX-2/PGE2 signalling in the angiogenic response of ECs to hypoxia. The results demonstrated that short-term hypoxic treatment enhanced HUVECs proliferation, migration, tube formation, significantly up-regulated COX-2, VEGF, AQP1 mRNA level, protein expression and promoted PGE2, VEGF release. The pharmacological inhibition study revealed that exposure of HUVEC to NS398 and AH6809 under hypoxia impaired the biological responses of ECs to hypoxia. Exogenous PGE2 augments the effects of hypoxia on HUVECs, and partially reversed the inhibitory effects of NS398 on HUVECs proliferation and angiogenic capability. Short-term hypoxic treatment enhanced angiogenic capability of ECs, and COX-2/PGE2 signalling may play a critical role in the biological response of ECs to hypoxia.
引用
收藏
页码:1840 / 1855
页数:16
相关论文
共 70 条
[11]   Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells [J].
Casibang, M ;
Purdom, S ;
Jakowlew, S ;
Neckers, L ;
Zia, F ;
Ben-Av, P ;
Hla, T ;
You, L ;
Jablons, DM ;
Moody, TW .
LUNG CANCER, 2001, 31 (2-3) :203-212
[12]   Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression [J].
Chang, SH ;
Liu, CH ;
Conway, R ;
Han, DK ;
Nithipatikom, K ;
Trifan, OC ;
Lane, TF ;
Hla, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :591-596
[13]  
Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581
[14]   Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697) [J].
Churchman, Adrian ;
Baydoun, Anwar R. ;
Hoffman, Richard .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 573 (1-3) :176-183
[15]  
de Castro-Bernas G, 2003, CLIN HEMORHEOL MICRO, V29, P199
[16]   Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis [J].
Dor, Y ;
Porat, R ;
Keshet, E .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1367-C1374
[17]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188
[18]   Endothelial cell responses to hypoxic stress [J].
Faller, DV .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (01) :74-84
[19]   Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts [J].
Faour, WH ;
He, YL ;
He, QW ;
de Ladurantaye, M ;
Quintero, M ;
Mancini, A ;
Di Battista, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31720-31731
[20]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25